Skip Header

Contribute Send feedback
Read comments (?) or add your own

P05696 (KPCA_RAT) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 136. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (2) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Protein kinase C alpha type

Short name=PKC-A
Short name=PKC-alpha
EC=2.7.11.13
Gene names
Name:Prkca
Synonyms:Pkca
OrganismRattus norvegicus (Rat)
Taxonomic identifier10116 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeRattus

Protein attributes

Sequence length672 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Depending on the cell type, is involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation. In cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Depending on the cell type, exhibits anti-apoptotic function and protects cells from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, or mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Ref.4 Ref.5 Ref.6

Catalytic activity

ATP + a protein = ADP + a phosphoprotein.

Cofactor

Binds 3 calcium ions per subunit. The ions are bound to the C2 domain By similarity.

Enzyme regulation

Classical (or conventional) PKCs (PRKCA, PRKCB and PRKCG) are activated by calcium and diacylglycerol (DAG) in the presence of phosphatidylserine. Three specific sites; Thr-497 (activation loop of the kinase domain), Thr-638 (turn motif) and Ser-657 (hydrophobic region), need to be phosphorylated for its full activation.

Subunit structure

Interacts with ADAP1/CENTA1, CSPG4 and PRKCABP. Binds to SDPR in the presence of phosphatidylserine By similarity. Interacts with PICK1 (via PDZ domain) By similarity. Interacts with TRIM41 By similarity. Recruited in a circadian manner into a nuclear complex which also includes BMAL1 and GNB2L1/RACK1 By similarity. Ref.3

Subcellular location

Cytoplasm. Cell membrane; Peripheral membrane protein. Mitochondrion membrane; Peripheral membrane protein By similarity. Nucleus. Note: Translocated to the nucleus upon treatment with PMA or IGF1. Ref.6 Ref.9

Sequence similarities

Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.

Contains 1 AGC-kinase C-terminal domain.

Contains 1 C2 domain.

Contains 2 phorbol-ester/DAG-type zinc fingers.

Contains 1 protein kinase domain.

Ontologies

Keywords
   Biological processAngiogenesis
Apoptosis
Cell adhesion
   Cellular componentCell membrane
Cytoplasm
Membrane
Mitochondrion
Nucleus
   DomainRepeat
Zinc-finger
   LigandATP-binding
Calcium
Metal-binding
Nucleotide-binding
Zinc
   Molecular functionKinase
Serine/threonine-protein kinase
Transferase
   PTMAcetylation
Phosphoprotein
   Technical term3D-structure
Complete proteome
Reference proteome
Gene Ontology (GO)
   Biological processaging

Inferred from expression pattern. Source: RGD

central nervous system neuron axonogenesis

Inferred from mutant phenotype. Source: RGD

establishment of protein localization

Traceable author statement. Source: UniProtKB

intracellular signal transduction

Inferred from direct assay. Source: RGD

learning or memory

Inferred from mutant phenotype. Source: RGD

negative regulation of heart contraction

Inferred from mutant phenotype. Source: RGD

negative regulation of translation

Inferred from mutant phenotype. Source: RGD

peptidyl-serine phosphorylation

Inferred from direct assay. Source: RGD

positive regulation of exocytosis

Inferred from mutant phenotype. Source: RGD

positive regulation of smooth muscle cell proliferation

Inferred from mutant phenotype. Source: RGD

positive regulation of synapse assembly

Inferred from mutant phenotype. Source: RGD

protein autophosphorylation

Inferred from direct assay. Source: RGD

regulation of receptor-mediated endocytosis

Inferred from mutant phenotype. Source: RGD

response to antibiotic

Inferred from expression pattern. Source: RGD

response to corticosterone stimulus

Inferred from expression pattern. Source: RGD

response to estradiol stimulus

Inferred from mutant phenotype. Source: RGD

response to ethanol

Inferred from mutant phenotype. Source: RGD

response to mechanical stimulus

Inferred from expression pattern. Source: RGD

response to organic cyclic compound

Inferred from expression pattern. Source: RGD

response to peptide hormone stimulus

Inferred from expression pattern. Source: RGD

response to reactive oxygen species

Inferred from mutant phenotype. Source: RGD

response to toxin

Inferred from expression pattern. Source: RGD

   Cellular componentcytosol

Inferred from direct assay. Source: RGD

membrane raft

Inferred from direct assay. Source: RGD

mitochondrion

Inferred from direct assay. Source: RGD

nucleus

Inferred from electronic annotation. Source: UniProtKB-SubCell

plasma membrane

Inferred from direct assay. Source: RGD

protein complex

Inferred from direct assay. Source: RGD

synaptosome

Inferred from direct assay. Source: RGD

   Molecular functionATP binding

Inferred from electronic annotation. Source: UniProtKB-KW

calcium-dependent protein kinase C activity

Inferred from direct assay. Source: RGD

zinc ion binding

Inferred from electronic annotation. Source: InterPro

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Initiator methionine11Removed By similarity
Chain2 – 672671Protein kinase C alpha type
PRO_0000055682

Regions

Domain172 – 26089C2
Domain339 – 597259Protein kinase
Domain598 – 66871AGC-kinase C-terminal
Zinc finger36 – 8651Phorbol-ester/DAG-type 1
Zinc finger101 – 15151Phorbol-ester/DAG-type 2
Nucleotide binding345 – 3539ATP By similarity

Sites

Active site4631Proton acceptor By similarity
Metal binding1861Calcium 1; via carbonyl oxygen
Metal binding1871Calcium 1
Metal binding1871Calcium 2
Metal binding1931Calcium 2
Metal binding2461Calcium 1
Metal binding2461Calcium 2
Metal binding2471Calcium 2; via carbonyl oxygen
Metal binding2481Calcium 1
Metal binding2481Calcium 2
Metal binding2481Calcium 3
Metal binding2521Calcium 3; via carbonyl oxygen
Metal binding2541Calcium 1
Metal binding2541Calcium 3
Binding site1951Inositol phosphate group
Binding site2451Inositol phosphate group
Binding site3681ATP By similarity

Amino acid modifications

Modified residue21N-acetylalanine By similarity
Modified residue1951Phosphotyrosine By similarity
Modified residue2081Phosphoserine By similarity
Modified residue2261Phosphoserine By similarity
Modified residue2501Phosphothreonine; by autocatalysis By similarity
Modified residue3191Phosphoserine By similarity
Modified residue4941Phosphothreonine By similarity
Modified residue4951Phosphothreonine By similarity
Modified residue4971Phosphothreonine; by PDPK1 By similarity
Modified residue5011Phosphothreonine By similarity
Modified residue6041N6-acetyllysine By similarity
Modified residue6281N6-acetyllysine By similarity
Modified residue6311Phosphothreonine; by autocatalysis Potential
Modified residue6381Phosphothreonine; by autocatalysis By similarity
Modified residue6571Phosphoserine By similarity
Modified residue6581Phosphotyrosine; by SYK By similarity

Experimental info

Mutagenesis1951Y → S: Reduced phosphatidylinositol 4,5-bisphosphate recognition and impaired membrane docking. Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with A-209; A-211 and A-245. Ref.9
Mutagenesis2091K → A: Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with S-195; A-211 and A-245. Ref.9
Mutagenesis2111K → A: Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with S-195; A-209 and A-245. Ref.9
Mutagenesis2451W → A: Reduced phosphatidylinositol 4,5-bisphosphate recognition and impaired membrane docking. Loss of phosphatidylinositol 4,5-bisphosphate-binding and strong decrease of membrane docking; when associated with S-195; A-209 and A-211. Ref.9

Secondary structure

........................ 672
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
P05696 [UniParc].

Last modified January 23, 2007. Version 3.
Checksum: 94889E7339C17719

FASTA67276,792
        10         20         30         40         50         60 
MADVYPANDS TASQDVANRF ARKGALRQKN VHEVKDHKFI ARFFKQPTFC SHCTDFIWGF 

        70         80         90        100        110        120 
GKQGFQCQVC CFVVHKRCHE FVTFSCPGAD KGPDTDDPRS KHKFKIHTYG SPTFCDHCGS 

       130        140        150        160        170        180 
LLYGLIHQGM KCDTCDMNVH KQCVINVPSL CGMDHTEKRG RIYLKAEVTD EKLHVTVRDA 

       190        200        210        220        230        240 
KNLIPMDPNG LSDPYVKLKL IPDPKNESKQ KTKTIRSTLN PQWNESFTFK LKPSDKDRRL 

       250        260        270        280        290        300 
SVEIWDWDRT TRNDFMGSLS FGVSELMKMP ASGWYKLLNQ EEGEYYNVPI PEGDEEGNVE 

       310        320        330        340        350        360 
LRQKFEKAKL GPAGNKVISP SEDRKQPSNN LDRVKLTDFN FLMVLGKGSF GKVMLADRKG 

       370        380        390        400        410        420 
TEELYAIKIL KKDVVIQDDD VECTMVEKRV LALLDKPPFL TQLHSCFQTV DRLYFVMEYV 

       430        440        450        460        470        480 
NGGDLMYHIQ QVGKFKEPQA VFYAAEISIG LFFLHKRGII YRDLKLDNVM LDSEGHIKIA 

       490        500        510        520        530        540 
DFGMCKEHMM DGVTTRTFCG TPDYIAPEII AYQPYGKSVD WWAYGVLLYE MLAGQPPFDG 

       550        560        570        580        590        600 
EDEDELFQSI MEHNVSYPKS LSKEAVSICK GLMTKHPAKR LGCGPEGERD VREHAFFRRI 

       610        620        630        640        650        660 
DWEKLENREI QPPFKPKVCG KGAENFDKFF TRGQPVLTPP DQLVIANIDQ SDFEGFSYVN 

       670 
PQFVHPILQS AV 

« Hide

References

[1]"Nucleotide sequences of cDNAs for alpha and gamma subspecies of rat brain protein kinase C."
Ono Y., Fujii T., Igarashi K., Kikkawa U., Ogita K., Nishizuka Y.
Nucleic Acids Res. 16:5199-5200(1988) [PubMed: 3387228] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Brain.
[2]"The common structure and activities of four subspecies of rat brain protein kinase C family."
Kikkawa U., Ogita K., Ono Y., Asaoka Y., Shearman M.S., Fujii T., Ase K., Sekiguchi K., Igarashi K., Nishizuka Y.
FEBS Lett. 223:212-216(1987) [PubMed: 3666147] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Brain.
[3]"Targeting of protein kinase Calpha to caveolae."
Mineo C., Ying Y.-S., Chapline C., Jaken S., Anderson R.G.W.
J. Cell Biol. 141:601-610(1998) [PubMed: 9566962] [Abstract]
Cited for: INTERACTION WITH SDPR.
[4]"Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium."
Frey M.R., Clark J.A., Leontieva O., Uronis J.M., Black A.R., Black J.D.
J. Cell Biol. 151:763-778(2000) [PubMed: 11076962] [Abstract]
Cited for: FUNCTION IN CELL CYCLE ARREST.
[5]"PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2)."
Braz J.C., Bueno O.F., De Windt L.J., Molkentin J.D.
J. Cell Biol. 156:905-919(2002) [PubMed: 11864993] [Abstract]
Cited for: FUNCTION IN CARDIAC HYPETROPHY.
[6]"Protein kinase C-alpha-induced hypertrophy of neonatal rat ventricular myocytes."
Vijayan K., Szotek E.L., Martin J.L., Samarel A.M.
Am. J. Physiol. 287:H2777-H2789(2004) [PubMed: 15271671] [Abstract]
Cited for: FUNCTION IN HEART FAILURE, SUBCELLULAR LOCATION.
[7]"The molecular heterogeneity of protein kinase C and its implications for cellular regulation."
Nishizuka Y.
Nature 334:661-665(1988) [PubMed: 3045562] [Abstract]
Cited for: REVIEW.
[8]"Ca(2+) bridges the C2 membrane-binding domain of protein kinase Calpha directly to phosphatidylserine."
Verdaguer N., Corbalan-Garcia S., Ochoa W.F., Fita I., Gomez-Fernandez J.C.
EMBO J. 18:6329-6338(1999) [PubMed: 10562545] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 155-293 IN COMPLEX WITH PHOSPHATIDYLSERINE.
[9]"Structural and mechanistic insights into the association of PKCalpha-C2 domain to PtdIns(4,5)P2."
Guerrero-Valero M., Ferrer-Orta C., Querol-Audi J., Marin-Vicente C., Fita I., Gomez-Fernandez J.C., Verdaguer N., Corbalan-Garcia S.
Proc. Natl. Acad. Sci. U.S.A. 106:6603-6607(2009) [PubMed: 19346474] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 156-292 IN COMPLEX WITH PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE, MUTAGENESIS OF TYR-195; LYS-209; LYS-211 AND TRP-245, SUBCELLULAR LOCATION.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
X07286 mRNA. Translation: CAA30266.1.
IPIIPI00201792.
PIRKIRTC. S02248.
UniGeneRn.207908.

3D structure databases

PDBe
RCSB PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
1DSYX-ray2.60A155-293[»]
3GPEX-ray2.00A156-292[»]
3RDJX-ray1.90A156-292[»]
3TWYX-ray1.50A156-292[»]
ProteinModelPortalP05696.
SMRP05696. Positions 37-292, 336-666.
ModBaseSearch...

Protein-protein interaction databases

IntActP05696. 2 interactions.
MINTMINT-86103.
STRINGP05696.

PTM databases

PhosphoSiteP05696.

Proteomic databases

PRIDEP05696.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Organism-specific databases

RGD3395. Prkca.

Phylogenomic databases

eggNOGmaNOG08253.
GeneTreeENSGT00590000082854.
HOVERGENHBG108317.
OrthoDBEOG40ZQX0.
PhylomeDBP05696.

Enzyme and pathway databases

BRENDA2.7.11.13. 5301.

Gene expression databases

ArrayExpressP05696.
GenevestigatorP05696.
GermOnlineENSRNOG00000003491. Rattus norvegicus.

Family and domain databases

InterProIPR000961. AGC-kinase_C.
IPR000008. C2_Ca-dep.
IPR008973. C2_Ca/lipid-bd_dom_CaLB.
IPR020477. C2_dom.
IPR018029. C2_membr_targeting.
IPR020454. DAG/PE-bd.
IPR011009. Kinase-like_dom.
IPR017892. Pkinase_C.
IPR002219. Prot_Kinase_C-like_PE/DAG-bd.
IPR000719. Prot_kinase_cat_dom.
IPR017441. Protein_kinase_ATP_BS.
IPR014375. Protein_kinase_C_a/b/g.
IPR017442. Se/Thr_kinase-like_dom.
IPR008271. Ser/Thr_kinase_AS.
IPR002290. Ser/Thr_kinase_dom.
[Graphical view]
PfamPF00130. C1_1. 2 hits.
PF00168. C2. 1 hit.
PF00069. Pkinase. 1 hit.
PF00433. Pkinase_C. 1 hit.
[Graphical view]
PIRSFPIRSF000550. PKC_alpha. 1 hit.
PRINTSPR00360. C2DOMAIN.
PR00008. DAGPEDOMAIN.
SMARTSM00109. C1. 2 hits.
SM00239. C2. 1 hit.
SM00133. S_TK_X. 1 hit.
SM00220. S_TKc. 1 hit.
[Graphical view]
SUPFAMSSF49562. C2_CaLB. 1 hit.
SSF56112. Kinase_like. 1 hit.
PROSITEPS51285. AGC_KINASE_CTER. 1 hit.
PS50004. C2. 1 hit.
PS00107. PROTEIN_KINASE_ATP. 1 hit.
PS50011. PROTEIN_KINASE_DOM. 1 hit.
PS00108. PROTEIN_KINASE_ST. 1 hit.
PS00479. ZF_DAG_PE_1. 2 hits.
PS50081. ZF_DAG_PE_2. 2 hits.
[Graphical view]
ProtoNetSearch...

Entry information

Entry nameKPCA_RAT
AccessionPrimary (citable) accession number: P05696
Entry history
Integrated into UniProtKB/Swiss-Prot: November 1, 1988
Last sequence update: January 23, 2007
Last modified: January 25, 2012
This is version 136 of the entry and version 3 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program

Relevant documents

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families